Disease Outcomes After Segmental Resection of Colonic Crohn’s Disease: A Retrospective Multicenter Study
Although high rates of recurrence persist within the postoperative phase of SC for CD, the postoperative use of TNFα inhibitor for prophylactic purposes for a subset of patients may promote a more durable endoscopic remission.
Authors
- Mark Lazarev (ORCID: https://orcid.org/0000-0002-5517-3588)
- S. Holubar
- M Silverberg
- Cristian Hernández-Rocha (ORCID: https://orcid.org/0000-0001-9018-4242)
- Christopher Bouvette (ORCID: https://orcid.org/0000-0003-3870-7469)
- B COHEN
- James Conner (ORCID: https://orcid.org/0000-0002-0731-8746)
- Oscar Hernandez Dominguez
- George Salem
Institutions
- Cleveland Clinic (US)
- Johns Hopkins University (US)
- Pontificia Universidad Católica de Chile (CL)
- University of Toronto (CA)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Oklahoma City University (US)
- Cleveland Foundation (US)
- Johns Hopkins Medicine (US)
- Oklahoma Foundation for Digestive Research (US)
- University of Oklahoma (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1093/ibd/izaf252
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00